Clinical Trial 44824

Birmingham, AL 35244


Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Eczema/Atopic Dermatitis


Treatment for patients with moderate to severe eczema. 

  1. Male or female subjects aged ≥ 12 years at the screening visit.
  2. Chronic eczema that has been documented for at least 2 years
  3. Involves more than 10% of body surface area

Qualified Participants May Receive:

  1. Payment for participating
  2. Travel expenses reimbursed 
  3. Treatment at no cost

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.